| Bioactivity | DB12055 (MK-0767 analog) is a covalent SARS-CoV-2 3CL protease inhibitor. DB12055 has the potential for the study of dyslipidemia and diabetes mellitus[1]. |
| CAS | 934017-32-0 |
| Formula | C20H17F3N2O5 |
| Molar Mass | 422.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ronda K Rippley, et al. Human pharmacokinetics and interconversion of enantiomers of MK-0767, a dual PPARalpha/gamma agonist. J Clin Pharmacol. 2007 Mar;47(3):323-33. [2]. Ying Wang, et al. Multidimensional virtual screening approaches combined with drug repurposing to identify potential covalent inhibitors of SARS-CoV-2 3CL protease. J Biomol Struct Dyn. 2023;41(24):15262-15285. |
DB12055
CAS: 934017-32-0 F: C20H17F3N2O5 W: 422.35
DB12055 (MK-0767 analog) is a covalent SARS-CoV-2 3CL protease inhibitor. DB12055 has the potential for the study of dys
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.